ARTICLES
Cloud Pharmaceuticals adds two executives
August 19, 2015
Remedy initiates phase IIa study of CIRARA
August 19, 2015
La Jolla receives FOP Orphan Drug designation
August 19, 2015
Three Questions: Wendy K.D. Selig, WSCollaborative
August 17, 2015
The truth about global health
August 17, 2015
Bioethicists warn of harm in ‘pay-to-play’ trials
August 17, 2015